Secukinumab treatment for ankylosing spondylitis and concomitant Huntington's disease: real-world experience

Basit Öğe Kaydı
dc.authoridBulut Gokten, Dilara/0000-0002-9226-7532
dc.contributor.authorGokten, D. Bulut
dc.contributor.authorMercan, R.
dc.date.accessioned2024-10-29T17:59:04Z
dc.date.available2024-10-29T17:59:04Z
dc.date.issued2024
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.26508/lsa.202302018
dc.identifier.endpage767
dc.identifier.issn0392-856X
dc.identifier.issn1593-098X
dc.identifier.issue3en_US
dc.identifier.pmid37877409
dc.identifier.startpage767
dc.identifier.urihttps://doi.org/10.26508/lsa.202302018
dc.identifier.urihttps://hdl.handle.net/20.500.11776/14611
dc.identifier.volume42
dc.identifier.wosWOS:001268638500014
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherClinical & Exper Rheumatology
dc.relation.ispartofClinical and Experimental Rheumatology
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleSecukinumab treatment for ankylosing spondylitis and concomitant Huntington's disease: real-world experience
dc.typeLetter

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu